Dr. Mitchell has more than 28 years of progressive leadership experience in clinical pharmacology and pharmacokinetics (PK). Dr. Mitchell has extensive expertise in all phases of development. His focus is on protocol design and planning, clinical and nonclinical PK data analysis/simulation, pharmacodynamic data analysis/interpretation, and representation at regulatory meetings. Dr. Mitchell’s therapeutic area experience includes oncology, immunology, rheumatology, and rare diseases. Dr. Mitchell has worked on 10 NDAs, 2 ANDAs, 2 BLAs, 20+ INDs, 100+ PK and population PK analyses.